Clinical Trial Update: Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update for a combination approach aimed at reducing stroke risk in routine treatment; results completed with posted results in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Northern California Institute of Research and Education | Conditions: Atherosclerosis, Adherence, Medication | Phase 2 | Status: COMPLETED | Results posted: 2023-12-20